BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RADA
2651
DELISTED
Rada Electronic Industries Ltd
RADA
| $93.9K | ﹤0.01% |
14,353
-5,224
| -27% | -$25.8K |
|
|
IMGN
2652
DELISTED
Immunogen Inc
IMGN
| $93.8K | ﹤0.01% |
20,396
-59,026
| -74% | -$251K |
|
|
TLRD
2653
DELISTED
Tailored Brands, Inc.
TLRD
| $93.7K | ﹤0.01% |
99,916
+78,235
| +361% | +$104K |
|
|
TRHC
2654
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $93.4K | ﹤0.01% |
1,706
-6,583
| -79% | -$377K |
|
2655
Vanguard Information Technology ETF
VGT
$150B
| $93.4K | ﹤0.01% |
2,680
-7,720
| -74% | -$241K |
|
2656
Toyota
TM
$226B
| $93.3K | ﹤0.01% |
743
-10,739
| -94% | -$1.33M |
|
2657
Canadian Pacific Kansas City
CP
$82.4B
| $92.9K | ﹤0.01% |
1,820
-650
| -26% | -$30.8K |
|
2658
Genesis Energy
GEL
$1.94B
| $92.7K | ﹤0.01% |
12,840
+3,067
| +31% | +$20.8K |
|
|
YMAB
2659
DELISTED
Y-mAbs Therapeutics
YMAB
| $92.3K | ﹤0.01% |
2,137
-8,198
| -79% | -$310K |
|
2660
Hope Bancorp
HOPE
$1.84B
| $92K | ﹤0.01% |
9,973
-41,534
| -81% | -$372K |
|
|
CADE
2661
DELISTED
Cadence Bancorporation
CADE
| $91.8K | ﹤0.01% |
10,364
-43,568
| -81% | -$311K |
|
2662
Enviri
NVRI
$579M
| $91.5K | ﹤0.01% |
6,774
-113,409
| -94% | -$1.14M |
|
2663
HSBC
HSBC
$356B
| $91.4K | ﹤0.01% |
3,917
+67
| +2% | +$1.66K |
|
|
MRSN
2664
DELISTED
Mersana Therapeutics
MRSN
| $91.3K | ﹤0.01% |
156
-289
| -65% | -$98.7K |
|
2665
Acushnet Holdings
GOLF
$5.23B
| $91.3K | ﹤0.01% |
2,623
-9,053
| -78% | -$269K |
|
2666
Brown-Forman Class A
BF.A
$13.3B
| $91.2K | ﹤0.01% |
1,584
-97
| -6% | -$5.66K |
|
|
ITCI
2667
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $91K | ﹤0.01% |
3,544
-13,486
| -79% | -$273K |
|
2668
Tanger
SKT
$4.41B
| $90.9K | ﹤0.01% |
12,748
-26,628
| -68% | -$176K |
|
|
VIVO
2669
DELISTED
Meridian Bioscience Inc
VIVO
| $90.2K | ﹤0.01% |
3,875
-13,939
| -78% | -$202K |
|
|
ACOR
2670
DELISTED
Acorda Therapeutics
ACOR
| $89.9K | ﹤0.01% |
1,020
+859
| +534% | +$90.8K |
|
|
INOV
2671
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $89.6K | ﹤0.01% |
4,650
-58,424
| -93% | -$1.04M |
|
|
TPIC
2672
DELISTED
TPI Composites
TPIC
| $88.5K | ﹤0.01% |
3,787
-5,159
| -58% | -$96.8K |
|
2673
Plains All American Pipeline
PAA
$16.8B
| $87K | ﹤0.01% |
9,836
-13,252
| -57% | -$113K |
|
2674
Palomar
PLMR
$3.39B
| $86.8K | ﹤0.01% |
1,012
-4,509
| -82% | -$299K |
|
|
CPRX
2675
DELISTED
Catalyst Pharmaceutical
CPRX
| $86.8K | ﹤0.01% |
18,783
-62,624
| -77% | -$281K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.